BioXcel Therapeutics
BTAI
BTAI
43 hedge funds and large institutions have $63.3M invested in BioXcel Therapeutics in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
Holders
43
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.34M | |
| 2 | +$956K | |
| 3 | +$658K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$384K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$281K |
Top Sellers
| 1 | -$1.68M | |
| 2 | -$1.12M | |
| 3 | -$898K | |
| 4 |
Squarepoint
New York
|
-$182K |
| 5 |
RA
Rational Advisors
Huntington,
New York
|
-$48K |